472 related articles for article (PubMed ID: 17608887)
21. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
Openshaw MS
Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
[TBL] [Abstract][Full Text] [Related]
22. Lowering the cost of prescription drugs.
Jindal B
J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276
[No Abstract] [Full Text] [Related]
23. Reference pricing for drugs: is it compatible with U.S. health care?
Kanavos P; Reinhardt U
Health Aff (Millwood); 2003; 22(3):16-30. PubMed ID: 12757268
[TBL] [Abstract][Full Text] [Related]
24. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
[TBL] [Abstract][Full Text] [Related]
25. The price of pharmaceuticals given managed care health insurance membership.
Brotman BA
Pharm Pract Manag Q; 2000 Jul; 20(2):16-9. PubMed ID: 11184047
[TBL] [Abstract][Full Text] [Related]
26. Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available.
Socal MP; Bai G; Anderson GF
JAMA Intern Med; 2019 Jun; 179(6):832-833. PubMed ID: 30882842
[TBL] [Abstract][Full Text] [Related]
27. RX for nosebleed prices.
Greenwald J
Time; 2001 May; 157(20):42-3. PubMed ID: 11383109
[No Abstract] [Full Text] [Related]
28. Affordable prescription drugs for NC consumers: the next challenge.
Savage HH
N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
[No Abstract] [Full Text] [Related]
29. Perspectives. Drug formularies pose legal threat to providers.
Moskowitz DB
Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
[No Abstract] [Full Text] [Related]
30. Senate postpones provider package, approves generic Rx bill.
Hosp Outlook; 2002; 5(4):3, 6. PubMed ID: 12219714
[No Abstract] [Full Text] [Related]
31. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
[No Abstract] [Full Text] [Related]
32. Drug importation and safety of drugs obtained from Canada.
Shepherd M
Ann Pharmacother; 2007 Jul; 41(7):1288-91. PubMed ID: 17578879
[TBL] [Abstract][Full Text] [Related]
33. Study: hospitalizations increase when only generic drugs are used for Medicare Advantage members.
Capitation Manag Rep; 2005 Mar; 12(3):30-2. PubMed ID: 15889631
[TBL] [Abstract][Full Text] [Related]
34. Pharmaceuticals and medical devices: cost savings.
Chaps NA
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-20. PubMed ID: 19297717
[No Abstract] [Full Text] [Related]
35. Toward a rational, value-based drug benefit for Medicare.
Lopert R; Moon M
Health Aff (Millwood); 2007; 26(6):1666-73. PubMed ID: 17978385
[TBL] [Abstract][Full Text] [Related]
36. [Generic medicines].
Peláez de Loño J
Rev Enferm; 1999 Dec; 22(12):836-43. PubMed ID: 10797771
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacists want to assume penalty].
MMW Fortschr Med; 2006 May; 148(20):55. PubMed ID: 16805194
[No Abstract] [Full Text] [Related]
38. Congressional healthcare outlook: prescription drugs.
Graham SB
Hosp Outlook; 2001 Jul; 4(5):6, 12. PubMed ID: 11478182
[No Abstract] [Full Text] [Related]
39. Pharmaceutical price controls at the state level.
Kozma CM
Manag Care Interface; 2001 Jul; 14(7):59-60. PubMed ID: 11481818
[No Abstract] [Full Text] [Related]
40. Substituting generic drugs: state roles.
Cauchi R
NCSL Legisbrief; 2009; 17(25):1-2. PubMed ID: 19526654
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
